BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29614442)

  • 61. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
    Terraf P; Pareja F; Brown DN; Ceyhan-Birsoy O; Misyura M; Rana S; O'Reilly E; Carlo MI; Aghajanian C; Liu Y; Derakhshan F; Jayakumaran G; Weigelt B; Walsh M; Stadler Z; Offit K; Ladanyi M; Robson M; Zehir A; Reis-Filho JS; Mandelker D
    Ann Oncol; 2022 Apr; 33(4):426-433. PubMed ID: 35074424
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
    Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
    PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toward Concurrent Testing for Somatic and Germline Variants in Cancer Patients.
    Mandelker D
    Clin Cancer Res; 2016 Aug; 22(16):3987-8. PubMed ID: 27307597
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas.
    Würtemberger J; Ripperger T; Vokuhl C; Bauer S; Teichert-von Lüttichau I; Wardelmann E; Niemeyer CM; Kratz CP; Schlegelberger B; Hettmer S
    Eur J Med Genet; 2023 May; 66(5):104718. PubMed ID: 36764384
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors.
    Akhavanfard S; Padmanabhan R; Yehia L; Cheng F; Eng C
    Nat Commun; 2020 May; 11(1):2206. PubMed ID: 32371905
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of a Genetic Evaluation Initiative to Increase Access to Genetic Services for Adolescent and Young Adults at a Tertiary Cancer Hospital.
    Makhnoon S; Corredor J; Arun B; Bell D; Yarbrough A; Livingston JA; Peterson SK; Roth M
    J Adolesc Young Adult Oncol; 2021 Jun; 10(3):296-302. PubMed ID: 32830989
    [No Abstract]   [Full Text] [Related]  

  • 67. Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
    Wilmott JS; Johansson PA; Newell F; Waddell N; Ferguson P; Quek C; Patch AM; Nones K; Shang P; Pritchard AL; Kazakoff S; Holmes O; Leonard C; Wood S; Xu Q; Saw RPM; Spillane AJ; Stretch JR; Shannon KF; Kefford RF; Menzies AM; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Scolyer RA
    Int J Cancer; 2019 Mar; 144(5):1049-1060. PubMed ID: 30178487
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Germline EGFR variants are over-represented in adolescents and young adults (AYA) with adrenocortical carcinoma.
    Akhavanfard S; Yehia L; Padmanabhan R; Reynolds JP; Ni Y; Eng C
    Hum Mol Genet; 2021 Jan; 29(22):3679-3690. PubMed ID: 33326033
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
    Konstantinopoulos PA; Norquist B; Lacchetti C; Armstrong D; Grisham RN; Goodfellow PJ; Kohn EC; Levine DA; Liu JF; Lu KH; Sparacio D; Annunziata CM
    J Clin Oncol; 2020 Apr; 38(11):1222-1245. PubMed ID: 31986064
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer.
    Wagener R; Taeubner J; Walter C; Yasin L; Alzoubi D; Bartenhagen C; Attarbaschi A; Classen CF; Kontny U; Hauer J; Fischer U; Dugas M; Kuhlen M; Borkhardt A; Brozou T
    Eur J Hum Genet; 2021 Aug; 29(8):1301-1311. PubMed ID: 33840814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
    Singhal D; Hahn CN; Feurstein S; Wee LYA; Moma L; Kutyna MM; Chhetri R; Eshraghi L; Schreiber AW; Feng J; Wang PP; Babic M; Parker WT; Gao S; Moore S; Das S; Thomas D; Pattnaik S; Brown AL; D'Andrea RJ; Poplawski NK; Thomas D; Scott HS; Godley LA; Hiwase DK
    Leukemia; 2021 Nov; 35(11):3245-3256. PubMed ID: 33850299
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer.
    Gheybi K; Jiang J; Mutambirwa SBA; Soh PXY; Kote-Jarai Z; Jaratlerdsiri W; Eeles RA; Bornman MSR; Hayes VM
    J Natl Compr Canc Netw; 2023 Mar; 21(3):289-296.e3. PubMed ID: 36898365
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.
    Rana HQ; Gelman R; LaDuca H; McFarland R; Dalton E; Thompson J; Speare V; Dolinsky JS; Chao EC; Garber JE
    J Natl Cancer Inst; 2018 Aug; 110(8):863-870. PubMed ID: 29529297
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.
    Wong W; Lowery MA; Berger MF; Kemel Y; Taylor B; Zehir A; Srinivasan P; Bandlamudi C; Chou J; Capanu M; Varghese A; Yu KH; Iacobuzio-Donahue CA; Shia J; Klimstra DS; Jarnagin WR; Stadler ZK; O'Reilly EM
    Cancer; 2019 May; 125(9):1441-1448. PubMed ID: 30620386
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board.
    Xavier CB; Link R; Abreu L; Bettoni F; Marson F; Galante PAF; Masotti C; Amano MT; de Molla V; Camargo AA; Asprino PF; Sabbaga J
    Oncologist; 2023 Jul; 28(7):624-627. PubMed ID: 37159554
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification and Management of
    Pal T; Brzosowicz J; Valladares A; Wiesner GL; Laronga C
    South Med J; 2017 Oct; 110(10):643-648. PubMed ID: 28973705
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with Sarcoma.
    Andrew EC; Lewin J; Desai J; Orme L; Hamilton A; Bae S; Zhu W; Nicolson S; Varghese LN; Mitchell CB; Vissers JHA; Xu H; Grimmond SM; Fox SB; Luen SJ
    J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392562
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ethical frameworks for obtaining informed consent in tumour profiling: an evidence-based case for Singapore.
    Bylstra Y; Lysaght T; Thrivikraman J; Watson S; Tan P
    Hum Genomics; 2017 Dec; 11(1):31. PubMed ID: 29221462
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nonmetropolitan residence and other factors affecting clinical trial enrollment for adolescents and young adults with cancer in a US population-based study.
    Mobley EM; Charlton ME; Ward MM; Lynch CF
    Cancer; 2019 Jul; 125(13):2283-2290. PubMed ID: 30901085
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
    Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
    J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.